📰 Local Recurrence News

Local Recurrence News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Local Recurrence. Real-time updates on events, politics, business and more.

Race/Ethnicity May Influence Local Recurrence in DCIS, Adjuvant Treatment

December 6, 2023

Disparities in 10-year local recurrence following breast-conserving surgery were seen among women with ductal carcinoma in situ (DCIS) treated over a nearly 4-decade span at Memorial Sloan Kettering Cancer Center, with Black women having the highest rate.

New York United States San Antonio Memorial Sloan Kettering Cancer Center Natalia Polidorio Department Of Surgery

Source: ajmc.com

PreludeDx™ to Present DCISionRT® and Novel Residual Risk Subtype Study Results During Scientific Oral Session at ASBrS 2022 Annual Meeting

March 29, 2022

/PRNewswire/ -- Prelude Corporation (PreludeDx™), a leader in molecular diagnostics and precision medicine for early-stage breast cancer, announced today that...

United States Pat Whitworth G Bruce Mann Andrew Wade Cory Dunn Frank Vicini

Source: prnewswire.com

DCISionRT by PreludeDx Identifies Women with DCIS with Unacceptably High Rates of Local Recurrence after Breast Conserving Surgery and Radiation Therapy

June 4, 2021

/PRNewswire/ -- Prelude Corporation (PreludeDx™), a leader in molecular diagnostics and precision medicine for early stage breast cancer, presented data at the...

United States Dan Forche Andrew Wade Cory Dunn Frank Vicini Prnewswire Prelude Corporation Preludedx

Source: prnewswire.com

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science

Navigation

Local Recurrence News Today

Race/Ethnicity May Influence Local Recurrence in DCIS, Adjuvant Treatment

PreludeDx&#x2122; to Present DCISionRT&#xAE; and Novel Residual Risk Subtype Study Results During Scientific Oral Session at ASBrS 2022 Annual Meeting

DCISionRT by PreludeDx Identifies Women with DCIS with Unacceptably High Rates of Local Recurrence after Breast Conserving Surgery and Radiation Therapy

Explore More Categories

PreludeDx™ to Present DCISionRT® and Novel Residual Risk Subtype Study Results During Scientific Oral Session at ASBrS 2022 Annual Meeting